Roivant Sciences Ltd.

Equities

ROIV

BMG762791017

Market Closed - Nasdaq Other stock markets 01:30:00 13/05/2026 am IST			5-day change	1st Jan Change
29.39 ^USD	+1.48%		+3.78%	+35.44%

06/05	Who is Vivek Ramaswamy, 2026 Republican nominee for Ohio governor?	RE
01/05	Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales	RE

Transcript : Roivant Sciences Ltd. - Analyst/Investor Day

Published on 12/12/2025 at 10:20 pm IST - Modified on 12/13/2025 at 04:10 am IST

S&P Capital IQ

Presenter Speech
Keyur Parekh (Executives)

Good morning, and thank you to those joining us in person on this cold New York morning. An equally warm welcome to those joining us virtually. My name is

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Roivant Sciences Ltd.

06/05	Who is Vivek Ramaswamy, 2026 Republican nominee for Ohio governor?	RE
01/05	Moderna first-quarter revenue jumps on strong overseas COVID vaccine sales	RE
01/05	Moderna tops revenue estimates on stronger international COVID vaccine sales	RE
23/04	Roivant Sciences Insider Sold Shares Worth $5,918,000, According to a Recent SEC Filing	MT
21/04	Roivant Sciences Insider Sold Shares Worth $8,449,810, According to a Recent SEC Filing	MT
02/04	Roivant Sciences Ltd. - Special Call
02/04	Roivant's Priovant Starts Phase 2b/3 Study of Brepocitinib in Inflammatory Scalp Disorder	MT
02/04	Roivant Sciences Ltd. Announces Expansion of Brepocitinib Development Program with New Phase 2b/3 Trial in Lichen Planopilaris and Phase 3 Study Results for Batoclimab in Thyroid Eye Disease	CI
02/04	Immunovant's treatment for eye disease fails in late-stage trials	RE
31/03	Roivant Sciences Insider Sold Shares Worth $1,921,500, According to a Recent SEC Filing	MT
29/03	New England Journal of Medicine publishes positive phase 3 valor trial results of brepocitinib in dermatomyositis	RE
20/03	Roivant Sciences Insider Sold Shares Worth $5,648,000, According to a Recent SEC Filing	MT
19/03	Roivant Sciences Insider Sold Shares Worth $1,200,573, According to a Recent SEC Filing	MT
11/03	Roivant Sciences Ltd. Presents at Leerink Global Healthcare Conference 2026, Mar-11-2026 08:40 AM
04/03	Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang	RE